Live Breaking News & Updates on இரத்தம் தண்டு செல்கள்

Stay updated with breaking news from இரத்தம் தண்டு செல்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Hyderabad-based Startup Develops Stem Cell Therapy for COVID


Hyderabad-based Startup Develops Stem Cell Therapy for COVID
by Angela Mohan on 
May 4, 2021 at 9:45 AM
Adult Mesenchymal Stem Cells (MSCs)-based therapy may hold potential in treating COVID-19 positive patients.
Transcell Oncologics has developed a proprietary cell-based platform technology, HEMATO UC-MSCs, with anti-cytokine storm properties, anti-inflammatory attributes and repairing abilities.
The treatment is associated with a significant decrease in a set of inflammatory cytokines involved in the COVID-19 cytokine storm , with significantly improved patient survival and time to recovery.
The research recommends HEMATO UC-MSCs to be administered as two intravenous infusions, at a dose of 100 million cells per infusion, given 72 hours apart to the COVID patients . ....

United States , Subadra Dravida , Transcell Oncologics , Cell Transplant Centre , Umiami Miller School Of Medicine , Jackson Health System , Department Of Public Health Sciences , Adult Mesenchymal Stem Cells , Miami Miller School , Public Health Sciences , Acute Respiratory Distress , Diet Plan , Lifestyle Modifications , Blood Stem Cells , Parkinsons Disease Surgical Treatmentgenetics , Stem Cellsreiki , Regenerative Medicinestem Cellsstem Cell , ஒன்றுபட்டது மாநிலங்களில் , மியாமி மில்லர் பள்ளி ஆஃப் மருந்து , ஜாக்சன் ஆரோக்கியம் அமைப்பு , துறை ஆஃப் பொது ஆரோக்கியம் அறிவியல் , மியாமி மில்லர் பள்ளி , பொது ஆரோக்கியம் அறிவியல் , எடுப்போசை சுவாச துன்பம் , உணவு திட்டம் , வாழ்க்கை மாற்றங்கள் ,

Stem Cells Heal Intestinal Disease in Premature Infants


Stem Cells Heal Intestinal Disease in Premature Infants
by Colleen Fleiss on 
May 1, 2021 at 1:16 AM
A human placental-derived stem cell (hPSC) therapy strategy is found to treat necrotizing enterocolitis (intestinal bowel disease) that affects up to 10 percent of premature infants.
The intestinal bowel disease is at a very vulnerable and developmentally crucial time can lead to serious infection and death.
The cause of necrotizing enterocolitis is unclear - it is a multi-faceted disease that results from the complex interaction of early bacterial colonization, an exaggerated inflammatory response, and immature intestinal tissue.
‘Necrotizing enterocolitis is a life-threatening intestinal disease that is a leading cause of mortality in premature infants and treatment options remain elusive.’ ....

United States , Anthony Atala , American Physiological Society , American Journal , Liver Physiology , Test Identifies Babies , Most Risk , Necrotizing Enterocolitis , Enterocolitis Prevented With Growth Factors , Milk Based Fortifiers Improve Health Outcome , Respiratory Syncytial Virus , Blood Stem Cells , Parkinsons Disease Surgical Treatmentgenetics , ஒன்றுபட்டது மாநிலங்களில் , அந்தோணி அதல , அமெரிக்கன் உடலியல் சமூகம் , அமெரிக்கன் இதழ் , கல்லீரல் உடலியல் , பெரும்பாலானவை ஆபத்து , இரத்தம் தண்டு செல்கள் ,